ENSAYO PARA LA DETERMINACIÓN DE BILIRRUBINA TOTAL
Mexico·Clase I·III. Agentes de diagnóstico·ABBOTT
LABORATORIES DE
MÉXICO, S.A. DE C.V.·Registered December 15, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ARCHITECT TOTAL BILIRUBIN2
- Trade Name (English)
- ARCHITECT TOTAL BILIRUBIN2
- Analysis ID
- 1603R2022 SSA
- Registration Date
- December 15, 2022
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN DE BILIRRUBINA TOTAL (ENSAYO PARA LA DETERMINACIÓN DE BILIRRUBINA TOTAL) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1603R2022 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on December 15, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.